<?xml version="1.0" encoding="UTF-8"?>
<results title="virus">
 <result pre="the United States and CanadaClin. Microbiol. Rev.199478911610.1128/CMR.7.1.898118792 2.HuneycuttB.S.BiZ.AokiC.J.ReissC.S.Central neuropathogenesis of" exact="vesicular stomatitis virus" post="infection of immunodeficient miceJ. Virol.199367669867068105106 3.Van den PolA.N.DaltonK.P.RoseJ.K.Relative neurotropism"/>
 <result pre="green fluorescent envelope glycoproteinJ. Virol.2002761309132710.1128/JVI.76.3.1309-1327.200211773406 4.Van den PolA.N.DavisJ.N.Highly attenuated recombinant" exact="vesicular stomatitis virus" post="VSV-12’GFP displays immunogenic and oncolytic activityJ. Virol.2013871019103410.1128/JVI.01106-1223135719 5.TylerK.L.Update on"/>
 <result pre="and CXCR4 coreceptors—Central to understanding the transmission and pathogenesis of" exact="human immunodeficiency virus" post="type 1 infectionAIDS Res. Hum. Retroviruses20042011112610.1089/08892220432274956715000703 19.DorrP.WestbyM.DobbsS.GriffinP.IrvineB.MacartneyM.MoriJ.RickettG.Smith-BurchnellC.NapierC.et al.Maraviroc (UK-427,"/>
 <result pre="Dispos.20053358759510.1124/dmd.104.00262615650075 46.WalkerD.K.BowersS.J.MitchellR.J.PotchoibaM.J.SchroederC.M.SmallH.F.Preclinical assessment of the distribution of maraviroc to potential" exact="human immunodeficiency virus" post="(HIV) sanctuary sites in the central nervous system (CNS)"/>
</results>
